BeOne Medicines Ltd.
ONC
58 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jun 11 8:23 PM | CHAN LEE | Proposed Sale | 428 | $257.64 | $110.3K | — | View → |
| Jun 11, 2026 | Jun 11 8:23 PM | JOHN OYLER | Proposed Sale | 1,949 | $257.24 | $501.4K | — | View → |
| Jun 8, 2026 | Jun 10 9:27 PM | Titus B. BallPrincipal Accounting Officer | Sale | 136 | $271.33 | $36.9K | 0(D) | View → |
| Jun 8, 2026 | Jun 10 9:26 PM | Chan Henry LeeSVP, General Counsel | Sale | 871 | $270.42 | $235.5K | 0(D) | View → |
| Jun 8, 2026 | Jun 10 9:25 PM | Lai WangPresident, Global Head of R&D | Sale | 1,367 | $269.38 | $368.2K | 0(D) | View → |
| Jun 8, 2026 | Jun 10 9:23 PM | Xiaobin WuPresident and COO | Sale | 1,484 | $269.37 | $399.7K | 0(D) | View → |
| Jun 8, 2026 | Jun 10 9:22 PM | John OylerDirector, Chief Executive Officer | Sale | 4,940 | $270.56 | $1.3M | 0(D) | View → |
| Jun 8, 2026 | Jun 8 8:31 PM | TITUS BENJAMIN BALL | Proposed Sale | 136 | $271.33 | $36.9K | — | View → |
| Jun 8, 2026 | Jun 8 8:29 PM | CHAN LEE | Proposed Sale | 871 | $270.42 | $235.5K | — | View → |
| Jun 8, 2026 | Jun 8 8:28 PM | LAI WANG | Proposed Sale | 1,367 | $269.38 | $368.2K | — | View → |
| Jun 8, 2026 | Jun 8 8:23 PM | XIAOBIN WU | Proposed Sale | 1,484 | $269.37 | $399.7K | — | View → |
| Jun 8, 2026 | Jun 8 8:18 PM | JOHN OYLER | Proposed Sale | 4,940 | $270.56 | $1.3M | — | View → |
| Jun 1, 2026 | Jun 3 8:10 PM | Qingqing YiDirector | Sale | 235 | $279.13 | $65.6K | 0(D) | View → |
| Jun 1, 2026 | Jun 1 8:27 PM | QINGQING YI | Proposed Sale | 235 | $279.13 | $65.6K | — | View → |
| May 22, 2026 | May 27 9:29 PM | Alessandro RivaDirector | Sale | 212 | $309.51 | $65.6K | 0(D) | View → |
| May 22, 2026 | May 27 9:26 PM | Margaret DuganDirector | Sale | 212 | $309.60 | $65.6K | 0(D) | View → |
| May 22, 2026 | May 27 9:26 PM | Corazon (Corsee) D. SandersDirector | Sale | 212 | $309.59 | $65.6K | 0(D) | View → |
| May 22, 2026 | May 27 8:54 PM | BAKER BROS. ADVISORS LPDirector | Sale | 10,998 | $23.82 | $262.0K | 142,570(I) | View → |
| May 22, 2026 | May 22 8:28 PM | MICHAEL GOLLER | Proposed Sale | 211 | $310.07 | $65.4K | — | View → |
| May 22, 2026 | May 22 8:25 PM | RANJEEV KRISHANA | Proposed Sale | 212 | $309.28 | $65.6K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 15 9:08 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 403,364(D) | View → |
| Sep 28, 2026 | Sep 30 9:11 PM | Xiaodong WangDirector, Other | Option Exercise | 403,364 | — | 806,715(D) | View → |
| Sep 8, 2026 | Sep 10 8:49 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 1,210,079(D) | View → |
| Aug 11, 2026 | Aug 14 12:54 AM | Chan Henry LeeSVP, General Counsel | Option Exercise | 34,658 | — | 88,582(D) | View → |
| Jul 22, 2026 | Jul 24 8:51 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,697 | — | 98,930(D) | View → |
| Jul 20, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 441,870 | — | 0(D) | View → |
| Jul 17, 2026 | Jul 17 9:36 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 840,164 | — | 441,870(D) | View → |
| Jul 16, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 2,165,761 | — | 1,282,034(D) | View → |
| Jul 15, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,515,241 | — | 1,254,513(D) | View → |
| Jul 14, 2026 | Jul 15 1:26 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,736,800 | — | 462,866(D) | View → |
| Jul 13, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 630,760 | — | 1,264,666(D) | View → |
| Jul 10, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 152,074 | — | 1,895,426(D) | View → |
| Jul 8, 2026 | Jul 10 8:44 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 8,632 | — | 105,300(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
Page 1 of 2
Next →